PubMed

Reduced-function SLC22A1 polymorphisms encoding organic cation transporter 1 and glycemic response to metformin: a GoDARTS study.

Zhou K, Donnelly LA, Kimber CH, Donnan PT, Doney AS, Leese G, Hattersley AT, McCarthy MI, Morris AD, Palmer CN, Pearson ER.

Diabetes. 2009 Jun;58(6):1434-9. Epub 2009 Mar 31.PMID: 19336679 [PubMed - indexed for MEDLINE]Related articlesFree article

Variation in TCF7L2 influences therapeutic response to sulfonylureas: a GoDARTs study.

Pearson ER, Donnelly LA, Kimber C, Whitley A, Doney AS, McCarthy MI, Hattersley AT, Morris AD, Palmer CN.

Diabetes. 2007 Aug;56(8):2178-82. Epub 2007 May 22.PMID: 17519421 [PubMed - indexed for MEDLINE]Related articlesFree article

Genetic variation in the organic cation transporter 1 is associated with metformin response in patients with diabetes mellitus.

Becker ML, Visser LE, van Schaik RH, Hofman A, Uitterlinden AG, Stricker BH.

Pharmacogenomics J. 2009 Aug;9(4):242-7. Epub 2009 Apr 21.PMID: 19381165 [PubMed - indexed for MEDLINE]Related articles

Loss of glycemic control in patients with type 2 diabetes mellitus who were receiving initial metformin, sulfonylurea, or thiazolidinedione monotherapy.

Riedel AA, Heien H, Wogen J, Plauschinat CA.

Pharmacotherapy. 2007 Aug;27(8):1102-10.PMID: 17655510 [PubMed - indexed for MEDLINE]Related articles

The effect of obesity on glycaemic response to metformin or sulphonylureas in Type 2 diabetes.

Donnelly LA, Doney AS, Hattersley AT, Morris AD, Pearson ER.

Diabet Med. 2006 Feb;23(2):128-33.PMID: 16433709 [PubMed - indexed for MEDLINE]Related articles

Effect of initial combination therapy with sitagliptin, a dipeptidyl peptidase-4 inhibitor, and metformin on glycemic control in patients with type 2 diabetes.

Goldstein BJ, Feinglos MN, Lunceford JK, Johnson J, Williams-Herman DE; Sitagliptin 036 Study Group.

Diabetes Care. 2007 Aug;30(8):1979-87. Epub 2007 May 7. Erratum in: Diabetes Care. 2008 Aug;31(8):1713. PMID: 17485570 [PubMed - indexed for MEDLINE]Related articlesFree article

Genetic variation in the multidrug and toxin extrusion 1 transporter protein influences the glucose-lowering effect of metformin in patients with diabetes: a preliminary study.

Becker ML, Visser LE, van Schaik RH, Hofman A, Uitterlinden AG, Stricker BH.

Diabetes. 2009 Mar;58(3):745-9. Epub 2009 Feb 19.PMID: 19228809 [PubMed - indexed for MEDLINE]Related articlesFree article

Improvements in glycemic control in type 2 diabetes patients switched from sulfonylurea coadministered with metformin to glyburide-metformin tablets.

Duckworth W, Marcelli M, Padden M, Kellick K, Duhancik T, Wilhardt M, Colgan K, Romie A.

J Manag Care Pharm. 2003 May-Jun;9(3):256-62.PMID: 14613469 [PubMed - indexed for MEDLINE]Related articlesFree article

United Kingdom Prospective Diabetes Study 24: a 6-year, randomized, controlled trial comparing sulfonylurea, insulin, and metformin therapy in patients with newly diagnosed type 2 diabetes that could not be controlled with diet therapy. United Kingdom Prospective Diabetes Study Group.

[No authors listed]

Ann Intern Med. 1998 Feb 1;128(3):165-75.PMID: 9454524 [PubMed - indexed for MEDLINE]Related articlesFree article

Outcomes of adding second hypoglycemic drug after metformin monotherapy failure among type 2 diabetes in Hungary.

Jermendy G; Hungarian RECAP Group, Erdesz D, Nagy L, Yin D, Phatak H, Karve S, Engel S, Balkrishnan R.

Health Qual Life Outcomes. 2008 Oct 31;6:88.PMID: 18976457 [PubMed - indexed for MEDLINE]Related articlesFree article

An open, randomized, parallel-group study to compare the efficacy and safety profile of inhaled human insulin (Exubera) with metformin as adjunctive therapy in patients with type 2 diabetes poorly controlled on a sulfonylurea.

Barnett AH, Dreyer M, Lange P, Serdarevic-Pehar M.

Diabetes Care. 2006 Jun;29(6):1282-7.PMID: 16732009 [PubMed - indexed for MEDLINE]Related articlesFree article

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.

Turner RC, Cull CA, Frighi V, Holman RR.

JAMA. 1999 Jun 2;281(21):2005-12.PMID: 10359389 [PubMed - indexed for MEDLINE]Related articlesFree article

Treatment escalation and rise in HbA1c following successful initial metformin therapy.

Nichols GA, Alexander CM, Girman CJ, Kamal-Bahl SJ, Brown JB.

Diabetes Care. 2006 Mar;29(3):504-9.PMID: 16505496 [PubMed - indexed for MEDLINE]Related articlesFree article

Glycemic response to newly initiated diabetes therapies.

Karter AJ, Moffet HH, Liu J, Parker MM, Ahmed AT, Go AS, Selby JV.

Am J Manag Care. 2007 Nov;13(11):598-606.PMID: 17988185 [PubMed - indexed for MEDLINE]Related articlesFree article

Efficacy of glyburide/metformin tablets compared with initial monotherapy in type 2 diabetes.

Garber AJ, Donovan DS Jr, Dandona P, Bruce S, Park JS.

J Clin Endocrinol Metab. 2003 Aug;88(8):3598-604.PMID: 12915642 [PubMed - indexed for MEDLINE]Related articlesFree article

Triple therapy in type 2 diabetes: insulin glargine or rosiglitazone added to combination therapy of sulfonylurea plus metformin in insulin-naive patients.

Rosenstock J, Sugimoto D, Strange P, Stewart JA, Soltes-Rak E, Dailey G.

Diabetes Care. 2006 Mar;29(3):554-9.PMID: 16505505 [PubMed - indexed for MEDLINE]Related articlesFree article

Antidiabetic prescriptions and glycemic control in German patients with type 2 diabetes mellitus: a retrospective database study.

Yurgin N, Secnik K, Lage MJ.

Clin Ther. 2007 Feb;29(2):316-25.PMID: 17472823 [PubMed - indexed for MEDLINE]Related articles

Secondary failure of glycemic control for patients adding thiazolidinedione or sulfonylurea therapy to a metformin regimen.

Riedel AA, Heien H, Wogen J, Plauschinat CA.

Am J Manag Care. 2007 Aug;13(8):457-63.PMID: 17685826 [PubMed - indexed for MEDLINE]Related articlesFree article

Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.

Robbins DC, Beisswenger PJ, Ceriello A, Goldberg RB, Moses RG, Pagkalos EM, Milicevic Z, Jones CA, Sarwat S, Tan MH.

Clin Ther. 2007 Nov;29(11):2349-64.PMID: 18158076 [PubMed - indexed for MEDLINE]Related articles

[Efficacy and safety of the use of metformin in patients with chronic heart failure and type 2 diabetes mellitus. results of the study "rational effective mulicomponent therapy in the battle against diabetes mellitus in patients with chronic heart failure"]

Lapina IuV, Narusov OIu, Mareev VIu, Bolotina MG, Shestakova MV, Masenko VP, Litonova GN, Arzamastseva NE, Baklanova NA, Belenkov IuN.

Kardiologiia. 2008;48(3):58-68. Russian. PMID: 18429758 [PubMed - indexed for MEDLINE]Related articles